Walmart to increase number of solar energy projects
MOUNTAIN VIEW, Calif. — Walmart said during an event with President Obama that it will double the number of on-site solar energy projects at its U.S. stores, Sam’s Clubs and distribution centers by 2020. The commitment is part of Walmart’s global initiative to drive the production or procurement of 7 billion kWh of renewable energy by the end of 2020.
“We share the president’s commitment to a sustainable energy future and applaud his willingness to partner with business on this important issue,” said Bill Simon, president and CEO of Walmart U.S. “We know from experience that investing in energy innovation allows us to save money, reduce carbon pollution and create jobs. Every day, millions of Americans depend on us to watch every penny so that we can provide the best prices on products they love. Our customers can feel good that we’re watching out for both their wallets and their children’s future.”
Walmart made the announcement while hosting President Obama at a solar-powered store in Mountain View, Calif. The president visited the store to highlight the importance of energy efficiency and renewables in keeping America strong.
Since 2005, Walmart’s greenhouse gas emissions grew at only one-quarter the rate of the company’s growth, nearly flatlining in recent years, the company said in a press release. With its 2020 energy goals, it anticipates an absolute decline in GHG emissions by 2020 despite significant growth plans over that same time period.
Report: Food City names VP of pharmacy operations
ABINGDON, Va. — Food City has reportedly appointed Mickey Blazer to the position of VP of pharmacy operations, according to a local news report.
According to a news article on swvatoday.com, Blazer has served as the departmental director since 2011, and worked as pharmacy operations manager prior to that. He holds more than 37 years of service with the company, six years of which have been spent in pharmacy management, collaborating with other members of senior management and store operations to supervise and oversee Food City’s 77 pharmacy locations.
FDA approves Zontivity tabs
SILVER SPRING, Md. — The Food and Drug Administration on Thursday approved Zontivity (vorapaxar) tablets, an anti-platelet agent that’s designed to decrease the tendency of platelets to clump together to form a blood clot. Zontivity is the first in a new class of drugs called a protease-activated receptor-1 (PAR-1) antagonist, the agency said.
“In patients who have had a heart attack or who have peripheral arterial disease, this drug will lower the risk of heart attack, stroke and cardiovascular death. In the study that supported the drug’s approval, Zontivity lowered this risk from 9.5% to 7.9% over a 3-year period — about 0.5% per year,” said Ellis Unger, M.D., director of the Office of Drug Evaluation I in the FDA’s Center for Drug Evaluation and Research.
Zontivity, similar to other drugs that inhibit blood clotting, increases the risk of bleeding, which includes life-threatening and fatal bleeding. The drug is not to be used in people who have suffered a stroke, transient ischemic attack or bleeding in the head, as the risk of bleeding in the head is too great.
Zontivity is made by Merck Sharp and Dohme Corp., a subsidiary of Merck of Whitehouse Station, N.J.